chr6-32166518-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_030652.4(EGFL8):āc.122A>Gā(p.Gln41Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000725 in 1,613,788 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_030652.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EGFL8 | NM_030652.4 | c.122A>G | p.Gln41Arg | missense_variant | 3/9 | ENST00000333845.11 | NP_085155.1 | |
EGFL8 | NR_037860.2 | n.237A>G | non_coding_transcript_exon_variant | 3/9 | ||||
PPT2-EGFL8 | NR_037861.1 | n.1639A>G | non_coding_transcript_exon_variant | 10/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EGFL8 | ENST00000333845.11 | c.122A>G | p.Gln41Arg | missense_variant | 3/9 | 1 | NM_030652.4 | ENSP00000333380.6 | ||
PPT2-EGFL8 | ENST00000422437.5 | n.*54A>G | non_coding_transcript_exon_variant | 11/21 | 5 | ENSP00000457534.1 | ||||
PPT2-EGFL8 | ENST00000422437.5 | n.*54A>G | 3_prime_UTR_variant | 11/21 | 5 | ENSP00000457534.1 |
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000887 AC: 22AN: 248042Hom.: 0 AF XY: 0.0000668 AC XY: 9AN XY: 134780
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461490Hom.: 0 Cov.: 31 AF XY: 0.0000371 AC XY: 27AN XY: 727054
GnomAD4 genome AF: 0.000322 AC: 49AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2024 | The c.122A>G (p.Q41R) alteration is located in exon 3 (coding exon 2) of the EGFL8 gene. This alteration results from a A to G substitution at nucleotide position 122, causing the glutamine (Q) at amino acid position 41 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at